← back to search

Shira Gabizon–Peretz

Hebrew University of Jerusalem · IL
Area of research
Cardiology and Cardiovascular Medicine · Biomaterials
Research interest
Research interests include Medicine, Cardiotoxicity, Nanomedicine, Cancer, Pharmacology, and Hormone replacement therapy (female-to-male).
h-index
—
citations
116
works
2
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

Thirty years from FDA approval of pegylated liposomal doxorubicin (Doxil/Caelyx): an updated analysis and future perspective
BMJ Oncology 2025cited by 81position: middledoi
Breast cancer risk and hormone replacement therapy among BRCA carriers after risk-reducing salpingo-oophorectomy
European Journal of Cancer 2021cited by 35position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Shani Paluch–Shimon · Hebrew University of Jerusalem1 papers (2021–2021)— · 1 papers (2025–2025)Pnina Mor · Hebrew University of Jerusalem1 papers (2021–2021)— · 1 papers (2025–2025)Rachel Michaelson‐Cohen · Hebrew University of Jerusalem1 papers (2021–2021)Ephrat Levy‐Lahad · Hebrew University of Jerusalem1 papers (2021–2021)Alberto Gabizón · Hebrew University of Jerusalem1 papers (2025–2025)Ariela Tomer · Hebrew University of Jerusalem1 papers (2021–2021)Shunit Armon · Hebrew University of Jerusalem1 papers (2021–2021)Naama Srebnik · Hebrew University of Jerusalem1 papers (2021–2021)